Coston McIsaac & Partners’s Albemarle ALB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-40
Closed -$5K 832
2025
Q4
$5K Hold
40
﹤0.01% 651
2025
Q3
$3K Hold
40
﹤0.01% 672
2025
Q2
$2K Hold
40
﹤0.01% 683
2025
Q1
$2K Hold
40
﹤0.01% 671
2024
Q4
$3K Hold
40
﹤0.01% 637
2024
Q3
$3 Hold
40
﹤0.01% 652
2024
Q2
$3K Hold
40
﹤0.01% 623
2024
Q1
$5K Hold
40
﹤0.01% 559
2023
Q4
$5K Hold
40
﹤0.01% 557
2023
Q3
$6K Hold
40
﹤0.01% 523
2023
Q2
$8K Hold
40
﹤0.01% 526
2023
Q1
$8K Hold
40
﹤0.01% 515
2022
Q4
$8 Hold
40
﹤0.01% 519
2022
Q3
$10K Hold
40
﹤0.01% 420
2022
Q2
$8K Buy
+40
New +$8.92K ﹤0.01% 292

Other funds holding ALB

Coston McIsaac & Partners's ALB Position: Q1 2026 in Review

Coston McIsaac & Partners sold out of Albemarle (ALB) in Q1 2026, closing a stake of 40 shares — an estimated $5K sold.

Coston McIsaac & Partners first reported a position in ALB in Q2 2022 and held it in 15 quarters. The position peaked at $10K in Q3 2022. 987 funds tracked by Wall St. Rank hold ALB as of Q1 2026.

  • Coston McIsaac & Partners reported no remaining Albemarle position as of Q1 2026 after selling out during the quarter.
  • Coston McIsaac & Partners sold 40 Albemarle shares in Q1 2026, an estimated $5K.
  • Coston McIsaac & Partners first reported a position in Albemarle in Q2 2022 and held it in 15 quarters.
  • Coston McIsaac & Partners's Albemarle position peaked at $10K in Q3 2022.
  • 987 funds tracked by Wall St. Rank held Albemarle as of Q1 2026.

Based on Coston McIsaac & Partners's 13F filing for Q1 2026, filed 22 Apr 2026.